Calliditas reveals results from vital NefIgArd study
The study concerns the use of Nefecon among adult patients with primary IgA nephropathy
Read More
Tag: calliditas
Calliditas reveals pivotal setanaxib data
Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
